Skip to content

Clinical trials

Terminated Cholangiocarcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Terminated Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20143
20195
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2
QED Therapeutics, a BridgeBio company2
AIO-Studien-gGmbH1
Concordia Laboratories Inc.1
Delcath Systems Inc.1
EMD Serono Research & Development Institute, Inc.1
Helsinn Healthcare SA1
Incyte Corporation1
NuCana plc1
PCI Biotech AS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma13
Biliary Tract Neoplasms4
Gallbladder Neoplasms4
Bile Duct Neoplasms3
Adenocarcinoma1
Camurati-Engelmann Syndrome1
Carcinoma, Adenoid Cystic1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Digestive System Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.